These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4066634)

  • 1. Federal regulation of commercial plasmapheresis centers.
    Solomon JM
    J Clin Apher; 1985; 2(4):368-71. PubMed ID: 4066634
    [No Abstract]   [Full Text] [Related]  

  • 2. Making blood money safe and respectable.
    White R
    FDA Consum; 1975 Dec-1976 Jan; 9(10):11-9. PubMed ID: 10305009
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safeguards for plasma donors in plasmapheresis programs.
    JAMA; 1970 Aug; 213(5):743-7. PubMed ID: 5468413
    [No Abstract]   [Full Text] [Related]  

  • 5. Collection of source material from remunerated donors.
    Rodell MB
    Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current plasmapheresis practices in the United States.
    Crispen JF
    Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current plasmapheresis practice in the United States.
    Tullis JL
    Ric Clin Lab; 1983; 13(1):11-9. PubMed ID: 6344176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis operations in the United States--1968.
    Hartney JB
    JAMA; 1970 Aug; 213(6):1023-5. PubMed ID: 5468172
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of plasmapheresis in France.
    Cazenave JP; Folléa G
    Hematol Cell Ther; 1996 May; 38 Suppl 1():S25-33. PubMed ID: 8933144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
    Volkow P; Perez-Padilla R; del-Rio C; Mohar A
    Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of the Bio-Rad protein microassay to a 96 well microtitre procedure for monitoring plasmapheresis donors.
    Howie RI; Murray SA; Wasi S
    Transfusion; 1989; 29(6):561-2. PubMed ID: 2749883
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
    Evers J; Taborski U
    J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of plasmapheresis in Italy.
    Baldini GM
    Hematol Cell Ther; 1996 May; 38 Suppl 1():S9-18. PubMed ID: 8933142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum donation volumes per session in donor plasmapheresis.
    Karger R; Kretschmer V
    Vox Sang; 2006 Nov; 91(4):350; author reply 351-2. PubMed ID: 17105614
    [No Abstract]   [Full Text] [Related]  

  • 17. Availability of plasma fractions for therapeutic use in Italy. (An introduction to the conference).
    Mannucci PM
    Ric Clin Lab; 1983; 13(1):1-4. PubMed ID: 6857093
    [No Abstract]   [Full Text] [Related]  

  • 18. The AIDS epidemic and commercial plasmapheresis.
    Volkow P
    Med Hypotheses; 1997 Dec; 49(6):521-3. PubMed ID: 9466378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The indices of quality of the donor's plasma, obtained by the methods of plasmapheresis and primary fractionation, using various hemopreservatives and leukocytic filters].
    Malyhon OI; Novak VL
    Klin Khir; 2014 Apr; (4):43-5. PubMed ID: 25097977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of centrifugal and membrane-based apheresis formats.
    Gurland HJ; Lysaght MJ; Samtleben W; Schmidt B
    Int J Artif Organs; 1984 Jan; 7(1):35-8. PubMed ID: 6698631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.